Search results: Sage Journals

Restricted accessLetterFirst published January, 2025

Effectiveness of Generic Tofacitinib in the Treatment of Patients with Mild Alopecia Areata in China: A Retrospective Real-World Study

Jia Jian, Min Li, Jundong Huang [...]

Journal of Cutaneous Medicine and Surgery

Open accessLetterFirst published June, 2022

The Perils of Generic Small Molecules: Has Tofacitinib Become a Toffee

Kunal Chandwar, Prasanna Dogga, Juhi Dixit [...]

Indian Journal of Rheumatology

Open accessResearch articleFirst published 2022

Fracture in clinical studies of tofacitinib in rheumatoid arthritis

Karen E. Hansen, Mahta Mortezavi, Edward Nagy [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2026

An inverse probability of treatment weighted comparison between vedolizumab,ustekinumab,and tofacitinib in anti-TNF-experienced ulcerative colitis patients

Antonio Tursi, Andrea Pasta, Walter Elisei [...]

Therapeutic Advances in Gastroenterology

Open accessReview articleFirst published 2025

Tofacitinib in acute severe ulcerative colitis: review addressing seven key unmet needs

Chuong Dinh Nguyen, Luan Minh Dang, Thong Duy Vo [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published 2022

Modified Mayo score versus Mayo score for evaluation of treatment efficacy in patients with ulcerative colitis: data from the tofacitinib OCTAVE program

William J. Sandborn, Bruce E. Sands, Séverine Vermeire [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published 2022

Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome

Jun Zou, Jian-fei Cai, Jing-fen Ye [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2023

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib

Lars E. Kristensen, Bruce Strober, Denis Poddubnyy [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2025

Prospective observational study of tofacitinib in ulcerative colitis – analysis of clinical data,fatigue and health-related quality of life during the induction phase

Lisa Nyberg, Jonas Halfvarson, Jonas Söderling [...]

Therapeutic Advances in Gastroenterology

Free accessReview articleFirst published February, 2013

The kinase inhibitor tofacitinib in patients with rheumatoid arthritis: latest findings and clinical potential

Maurizio Cutolo

Therapeutic Advances in Musculoskeletal Disease

Restricted accessLetterFirst published January, 2025

Effectiveness of Generic Tofacitinib in the Treatment of Patients with Mild Alopecia Areata in China: A Retrospective Real-World Study

Jia Jian, Min Li, Jundong Huang [...]

Journal of Cutaneous Medicine and Surgery

Open accessLetterFirst published June, 2022

The Perils of Generic Small Molecules: Has Tofacitinib Become a Toffee

Kunal Chandwar, Prasanna Dogga, Juhi Dixit [...]

Indian Journal of Rheumatology

Open accessResearch articleFirst published 2022

Fracture in clinical studies of tofacitinib in rheumatoid arthritis

Karen E. Hansen, Mahta Mortezavi, Edward Nagy [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2026

An inverse probability of treatment weighted comparison between vedolizumab,ustekinumab,and tofacitinib in anti-TNF-experienced ulcerative colitis patients

Antonio Tursi, Andrea Pasta, Walter Elisei [...]

Therapeutic Advances in Gastroenterology

Open accessReview articleFirst published 2025

Tofacitinib in acute severe ulcerative colitis: review addressing seven key unmet needs

Chuong Dinh Nguyen, Luan Minh Dang, Thong Duy Vo [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published 2022

Modified Mayo score versus Mayo score for evaluation of treatment efficacy in patients with ulcerative colitis: data from the tofacitinib OCTAVE program

William J. Sandborn, Bruce E. Sands, Séverine Vermeire [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published 2022

Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome

Jun Zou, Jian-fei Cai, Jing-fen Ye [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2023

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib

Lars E. Kristensen, Bruce Strober, Denis Poddubnyy [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2025

Prospective observational study of tofacitinib in ulcerative colitis – analysis of clinical data,fatigue and health-related quality of life during the induction phase

Lisa Nyberg, Jonas Halfvarson, Jonas Söderling [...]

Therapeutic Advances in Gastroenterology

Free accessReview articleFirst published February, 2013

The kinase inhibitor tofacitinib in patients with rheumatoid arthritis: latest findings and clinical potential

Maurizio Cutolo

Therapeutic Advances in Musculoskeletal Disease